Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 12, 15:44
1460.95
19.5 (1.35%)
VOLUME 48,988
LIVE
NSE
Dec 12, 15:58
1462.55
20 (1.39%)
VOLUME 793,781
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Sep '17 Jun '17 Mar '17 Dec '16 Sep '16
Net Sales/Income from operations 469.14 397.93 397.81 490.51 464.30
Other Operating Income -- -- 20.69 18.09 13.44
Total Income From Operations 469.14 397.93 418.50 508.60 477.74
EXPENDITURE
Consumption of Raw Materials 81.14 93.80 79.14 96.93 102.80
Purchase of Traded Goods 14.64 18.59 15.55 18.10 14.77
Increase/Decrease in Stocks 10.84 -32.39 -5.99 12.79 3.53
Power & Fuel -- -- -- -- --
Employees Cost 82.15 79.78 69.09 69.28 66.63
Depreciation 13.95 12.93 18.87 14.73 13.45
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 122.93 128.08 118.82 136.00 121.03
P/L Before Other Inc. , Int., Excpt. Items & Tax 143.49 97.14 123.02 160.77 155.53
Other Income 7.93 4.70 7.36 51.08 6.68
P/L Before Int., Excpt. Items & Tax 151.42 101.84 130.38 211.85 162.21
Interest 0.05 0.04 0.74 0.59 0.62
P/L Before Exceptional Items & Tax 151.37 101.80 129.64 211.26 161.59
Exceptional Items -- -- -- -- --
P/L Before Tax 151.37 101.80 129.64 211.26 161.59
Tax 43.67 25.07 21.67 40.28 40.64
P/L After Tax from Ordinary Activities 107.70 76.73 107.97 170.98 120.95
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 107.70 76.73 107.97 170.98 120.95
Equity Share Capital 17.69 17.69 17.69 17.69 17.69
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 12.24 8.72 12.27 19.42 13.75
Diluted EPS 12.23 8.72 12.27 19.42 13.74
EPS After Extra Ordinary
Basic EPS 12.24 8.72 12.27 19.42 13.75
Diluted EPS 12.23 8.72 12.27 19.42 13.74
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.